Drug Approved to Prevent Breast Cancer Recurrence (HealthDay)
13th Jan 2006, 06:11 GMT
The Novartis drug Femara (letrozole) has been approved by the U.S. Food and Drug Administration to prevent recurrence of hormone-sensitive early breast cancer among postmenopausal women.
Drug Approved to Prevent Breast Cancer Recurrence (HealthDay) related news:
- Man pleads for Herceptin — The Cancer Blog
- Fatigue Persists for Some Breast Cancer Patients (HealthDay) — Yahoo! News: Health News
- Certain gene increases benefits of tamoxifen — The Cancer Blog
- Right Amount of Radiation Improves Odds Against Breast Cancer (HealthDay) — Yahoo! Health: Breast Cancer News
- Medicare Contractor Establishes Reimbursement Coverage Policy for Genomic Health's Oncotype DX Breast Cancer Test — Government/ Industry Regulation News from StratCenter.com
- Kylie's publicist says cancer treatments are continuing — The Earth Times Online Newspaper - Entertainment News
- Genes affect benefits of breast cancer drug — KeralaNext: Health
- Faulty Breast Stem Cells May Cause Tumors (HealthDay) — Yahoo! Health: Breast Cancer News
- Genes affect benefits of breast cancer drug (Reuters) — Yahoo! News: Health News
- Breast cancer gets new treatment — The Cancer Blog